Dianthus Therapeutics | 现金及等价物



金融业
股票价格
USD
资产
USD 577.45M
现金及等价物
USD 55.98M
流动资产
USD 413.83M
流动负债
USD 23.86M
债务
USD 1.29M
EBIT
USD -40.29M
EBITDA
USD -40.19M
员工
53
EPS每股收益
USD -0.97
股本和储备
USD 546.45M
销售毛利
USD 396K
债务利息支出
USD 4.45M
利息收入
USD 3.66M
贷款资金
USD 0
市值
USD 1.52B
净收入
USD -36.76M
营业费用
USD 40.68M
营业利润
USD -40.29M
普通股股本
USD 42.85M
税前利润
USD -36.76M
销售收入
USD 396K
销售和管理费用
USD 8.2M
股票
384K
贸易债权人
USD 6.71M
应收帐款人
USD 5M


现金及等价物 更改 日
Akebia Therapeutics USD 184.84M 18.4M 2025-12
Alaunos Therapeutics USD 1.94M 941K 2025-09
Avita Medical AUD 12.22M 1.83M 2025-06
Celltrion KRW 29.65B 799.42B 2025-06
Cspc Pharmaceutical CNY 7.57B 793.73M 2025-06
Deva Holding AS TRY 775.92M 574.67M 2023-09
Dianthus Therapeutics USD 55.98M 42.75M 2025-09
Divis Laboratories Ltd INR 4.15B 31.87B 2025-03
IQVIA Holdings USD 1.98B 166M 2025-12
Kangmei Pharma CNY 1.18B 278M 2025-09
Knight Therapeutics CAD 77.82M 34.34M 2025-06
Laboratorios Farma EUR 46.11M 18.92M 2025-06
Malin Corporation EUR 62.1M 26.4M 2024-12
Medical Developments International AUD 17.84M 219K 2025-06
Moderna USD 2.6B 1.46B 2025-12
Neuren Pharmaceuticals AUD 5.91M 2.76M 2025-06
Organigram Holdings CAD 28.2M 7.68M 2025-09
Organon & Co USD 672M 73M 2025-09
Pharma Mar EUR 21.59M 38.7M 2025-06
Qiagen NV USD 1.36B 621.78M 2025-09
Revvity USD 919.86M 11.53M 2025-12
Sartorius EUR 389.9M 429.1M 2025-09
Sino Biopharmaceutical CNY 3.38B 2.09B 2024-12
Tectonic Therapeutic USD 268.44M 18.94M 2025-09
Tilray USD 264.83M 43.16M 2025-06
Viatris USD 1.32B 347.1M 2025-12
Xeris Pharmaceuticals USD 91.6M 32.32M 2025-09
Zz Pientze Pharmaceu CNY 1.77B 376.03M 2025-06


Dianthus Therapeutics 现金及等价物 - 当前值，历史数据，预测，统计，图表和经济日历 - Feb 2026.